| NCT03368027 |
Effectiveness of a Cognitive-behavioral Program of Coping With Psychological Stress in People With Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT03368027 |
Completed |
Universidad de Granada |
2018-12-03 |
| NCT03264885 |
Randomized Controlled Trial Evaluating an Incentive-based Community Eye-care Programme |
https://ClinicalTrials.gov/show/NCT03264885 |
Completed |
Singapore National Eye Centre |
2017-01-01 |
| NCT03212222 |
Cell Phone Application for Vision Assessment |
https://ClinicalTrials.gov/show/NCT03212222 |
Completed |
Duke University |
2017-12-15 |
| NCT03207477 |
Premavision Cohort Follow-up |
https://ClinicalTrials.gov/show/NCT03207477 |
Active, not recruiting |
Central Hospital, Nancy, France |
2020-06-30 |
| NCT03192722 |
Low Vision Patients’ Preference for Colored Filters and Illumination for Near Reading Determined by the LuxIQ/2 |
https://ClinicalTrials.gov/show/NCT03192722 |
Recruiting |
Nova Southeastern University |
2020-12-31 |
| NCT03174314 |
Feasibility and Efficacy of Assisstive Tactile and Auditory Communicating Devices |
https://ClinicalTrials.gov/show/NCT03174314 |
Recruiting |
NYU Langone Health |
2021-12-31 |
| NCT02911805 |
Bridging Animal and Human Models of Exercise-induced Visual Rehabilitation |
https://ClinicalTrials.gov/show/NCT02911805 |
Active, not recruiting |
VA Office of Research and Development |
2020-03-29 |
| NCT02680223 |
Efficacy of Coloured Overlays and Lenses for Reading Difficulty |
https://ClinicalTrials.gov/show/NCT02680223 |
Completed |
City, University of London |
2019-12-31 |
| NCT02679313 |
Effect of Lens Presentation on the Clinical Oculomotor Assessment at Near |
https://ClinicalTrials.gov/show/NCT02679313 |
Completed |
State University of New York College of Optometry |
2016-09-30 |
| NCT02669095 |
Clinical Evaluation of Approved and Investigational Contact Lenses |
https://ClinicalTrials.gov/show/NCT02669095 |
Completed |
Johnson & Johnson Vision Care, Inc. |
2016-03-31 |
| NCT02625233 |
Clinical Long-Term Evaluation of Approved and Investigational Contact Lenses |
https://ClinicalTrials.gov/show/NCT02625233 |
Completed |
Johnson & Johnson Vision Care, Inc. |
2016-02-01 |
| NCT02607384 |
The Baltimore Reading and Eye Disease Study |
https://ClinicalTrials.gov/show/NCT02607384 |
Completed |
Johns Hopkins University |
2016-07-31 |
| NCT02595502 |
Clinical Evaluation of Two Silicone Hydrogel Daily Disposable Contact Lenses |
https://ClinicalTrials.gov/show/NCT02595502 |
Completed |
Johnson & Johnson Vision Care, Inc. |
2015-11-01 |
| NCT03403959 |
Seasonal Affective Disorder and Visual Impairment |
https://ClinicalTrials.gov/show/NCT03403959 |
Recruiting |
Psychiatric Centre Rigshospitalet |
2020-03-01 |
| NCT02543528 |
A Clinical Trial to Evaluate Investigational Silicone Hydrogel Contact Lenses Worn Continuously for One Week |
https://ClinicalTrials.gov/show/NCT02543528 |
Completed |
Johnson & Johnson Vision Care, Inc. |
2016-11-08 |
| NCT02540122 |
Pilot Clinical Evaluation of Approved Contact Lenses |
https://ClinicalTrials.gov/show/NCT02540122 |
Completed |
Johnson & Johnson Vision Care, Inc. |
2016-06-30 |
| NCT02391961 |
Study and Treatment of Visual Dysfunction and Motor Fatigue in Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT02391961 |
Completed |
VA Office of Research and Development |
2019-01-31 |
| NCT02259088 |
A 12-month, Randomized, Efficacy and Safety Study of 0.5 mg Ranibizumab vs Laser in Chinese Diabetic Macular Edema (DME) Patients |
https://ClinicalTrials.gov/show/NCT02259088 |
Completed |
Novartis |
2017-01-17 |
| NCT02258113 |
Measuring of Neuro-visual Functionality With Ocusweep |
https://ClinicalTrials.gov/show/NCT02258113 |
Recruiting |
Ocuspecto Oy |
2021-12-31 |
| NCT02102958 |
Nonvisual Foot Examination for People With Diabetes and Visual Impairment |
https://ClinicalTrials.gov/show/NCT02102958 |
Completed |
Case Western Reserve University |
2013-12-31 |
| NCT01315275 |
A Clinical Study in Current Medical Practice of the Efficacy and Safety of Ranibizumab 0.5mg in Diabetic Patients Presenting a Visual Impairment Due to Macular Edema |
https://ClinicalTrials.gov/show/NCT01315275 |
Completed |
Novartis |
2012-08-31 |
| NCT02034006 |
A Study of the Criteria Establishing the Need for Re-treatment With Ranibizumab Upon Relapse in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia. |
https://ClinicalTrials.gov/show/NCT02034006 |
Completed |
Novartis |
2016-07-15 |
| NCT01922102 |
Efficacy and Safety of Ranibizumab 0.5 vs Verteporfin PDT in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia |
https://ClinicalTrials.gov/show/NCT01922102 |
Completed |
Novartis |
2016-09-14 |
| NCT01822717 |
Nonvisual Foot Inspection for People With Visual Imapirment |
https://ClinicalTrials.gov/show/NCT01822717 |
Completed |
Case Western Reserve University |
2012-09-30 |
| NCT01816087 |
Performances of a Brief Assessment Tool for the Early Diagnosis of Geriatric Syndromes by Primary Care Physicians |
https://ClinicalTrials.gov/show/NCT01816087 |
Completed |
University of Lausanne |
2014-11-30 |
| NCT01701700 |
The Effectiveness of Portable Electronic Vision Enhancement Systems (p-EVES) for Near Vision in Visual Impairment |
https://ClinicalTrials.gov/show/NCT01701700 |
Completed |
Manchester University NHS Foundation Trust |
2015-04-30 |
| NCT01698788 |
Effect of Intraoperative Dexamethasone Implant in Taut Posterior Hyaloid Removal in Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT01698788 |
Completed |
Postgraduate Institute of Medical Education and Research |
2011-12-31 |
| NCT01698749 |
Effect of Intravitreal Long Acting Dexamethasone Implant, Ozurdex in Patients With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT01698749 |
Completed |
Postgraduate Institute of Medical Education and Research |
2012-01-31 |
| NCT01691027 |
Visuomotor Rehabilitation Training for Manual Task Deficits From Macular Scotomas |
https://ClinicalTrials.gov/show/NCT01691027 |
Completed |
VA Office of Research and Development |
2015-07-31 |
| NCT01546402 |
Intraoperative Dexamethasone Implant Improves Outcome of Cataract Surgery With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT01546402 |
Completed |
Postgraduate Institute of Medical Education and Research |
2012-11-30 |
| NCT01535261 |
Ranibizumab Intravitreal Injections in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT01535261 |
Completed |
Novartis |
2015-03-31 |
| NCT01396083 |
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO) |
https://ClinicalTrials.gov/show/NCT01396083 |
Completed |
Novartis |
2014-01-31 |
| NCT01396057 |
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO) |
https://ClinicalTrials.gov/show/NCT01396057 |
Completed |
Novartis |
2013-06-30 |
| NCT01366677 |
Yoga for Persons With Severe Visual Impairment |
https://ClinicalTrials.gov/show/NCT01366677 |
Completed |
Johns Hopkins University |
2013-12-31 |
| NCT04158622 |
Retinal Displacement Rates in Pneumatic Retinopexy Versus Pars Plana Vitrectomy For Primary Retinal Detachment |
https://ClinicalTrials.gov/show/NCT04158622 |
Recruiting |
St. Michael’s Hospital, Toronto |
2021-12-31 |
| NCT04143620 |
Triple Procedure for Dense Cataractus Neovascular Glaucoma Patients |
https://ClinicalTrials.gov/show/NCT04143620 |
Completed |
Minia University |
2019-08-31 |
| NCT04141891 |
Advancing Understanding of Transportation Options |
https://ClinicalTrials.gov/show/NCT04141891 |
Recruiting |
University of Colorado, Denver |
2023-08-01 |
| NCT04123626 |
A Study to Evaluate the Safety and Tolerability of QR-1123 in Subjects With Autosomal Dominant Retinitis Pigmentosa Due to the P23H Mutation in the RHO Gene |
https://ClinicalTrials.gov/show/NCT04123626 |
Recruiting |
ProQR Therapeutics |
2021-10-07 |
| NCT04074642 |
OCT-angiography as a Pronostic Marker for Visual Impairment in Patients Undergoing Neurosurgery for Compressive Macroadenoma : a Prospective Study. |
https://ClinicalTrials.gov/show/NCT04074642 |
Recruiting |
Centre Hospitalier Universitaire de Nice |
2020-07-31 |
| NCT04035343 |
Effect of Type of Head Positioning on Retinal Displacement in Vitrectomy for Retinal Detachment |
https://ClinicalTrials.gov/show/NCT04035343 |
Recruiting |
St. Michael’s Hospital, Toronto |
2020-10-31 |
| NCT03957980 |
Remote Access: Cortical Visual Impairment |
https://ClinicalTrials.gov/show/NCT03957980 |
Completed |
Children’s Hospital Medical Center, Cincinnati |
2018-11-13 |
| NCT03922347 |
mHealth Intervention for Improving Eye Health at Community Level |
https://ClinicalTrials.gov/show/NCT03922347 |
Completed |
Shahid Beheshti University of Medical Sciences |
2018-05-15 |
| NCT03917472 |
Efficacy and Safety of Brolucizumab vs Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT03917472 |
Active, not recruiting |
Novartis |
2021-07-30 |
| NCT03913143 |
A Study to Evaluate Efficacy, Safety, Tolerability and Exposure After a Repeat-dose of Sepofarsen (QR-110) in LCA10 (ILLUMINATE) |
https://ClinicalTrials.gov/show/NCT03913143 |
Recruiting |
ProQR Therapeutics |
2020-12-31 |
| NCT03913130 |
Extension Study to Study PQ-110-001 (NCT03140969) |
https://ClinicalTrials.gov/show/NCT03913130 |
Active, not recruiting |
ProQR Therapeutics |
2021-03-31 |
| NCT03872479 |
Single Ascending Dose Study in Participants With LCA10 |
https://ClinicalTrials.gov/show/NCT03872479 |
Recruiting |
Allergan |
2024-03-22 |
| NCT03811366 |
Multimodal Analysis and Electroretinogram in VKH From Acute Onset - Part I |
https://ClinicalTrials.gov/show/NCT03811366 |
Completed |
University of Sao Paulo |
2017-01-31 |
| NCT03802630 |
Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Branch Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT03802630 |
Recruiting |
Novartis |
2023-05-26 |
| NCT03781583 |
SmartHMD for Improved Mobility |
https://ClinicalTrials.gov/show/NCT03781583 |
Recruiting |
University of Michigan |
2021-03-31 |
| NCT03780257 |
Study to Evaluate Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene |
https://ClinicalTrials.gov/show/NCT03780257 |
Recruiting |
ProQR Therapeutics |
2021-12-31 |
| NCT03763721 |
The ADVISE Study: Advanced Visualization In Corneal Surgery Evaluation |
https://ClinicalTrials.gov/show/NCT03763721 |
Recruiting |
UMC Utrecht |
2021-05-31 |
| NCT03640130 |
Peripheral Reading |
https://ClinicalTrials.gov/show/NCT03640130 |
Enrolling by invitation |
University of Houston |
2019-03-01 |
| NCT03592615 |
Binocular Vision Anomalies After Cataract and Refractive Surgery |
https://ClinicalTrials.gov/show/NCT03592615 |
Completed |
Salus University |
2019-11-26 |
| NCT03560765 |
Mobile Electronic Devices for Visual Impairment |
https://ClinicalTrials.gov/show/NCT03560765 |
Recruiting |
University of Manchester |
2020-07-01 |
| NCT03481660 |
A Study of the Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT03481660 |
Active, not recruiting |
Novartis |
2020-07-15 |
| NCT03481634 |
Study of Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT03481634 |
Active, not recruiting |
Novartis |
2020-11-11 |
| NCT03473431 |
Effect of Ketamine in Depressive Symptoms of Elderly Patients With Visual Impairment. |
https://ClinicalTrials.gov/show/NCT03473431 |
Completed |
Instituto Mexicano del Seguro Social |
2018-06-30 |
| NCT03455478 |
Shanghai Eye Study for Older People |
https://ClinicalTrials.gov/show/NCT03455478 |
Recruiting |
Shanghai Eye Disease Prevention and Treatment Center |
2018-11-30 |
| NCT01250210 |
Evaluation of Pharmacodynamic Effects on Ovulation and Cycle Control |
https://ClinicalTrials.gov/show/NCT01250210 |
Completed |
Agile Therapeutics |
2008-02-29 |
| NCT01217944 |
Efficacy and Safety of Ranibizumab in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia |
https://ClinicalTrials.gov/show/NCT01217944 |
Completed |
Novartis |
2012-08-31 |
| NCT01171976 |
Efficacy and Safety of Ranibizumab in Two “Treat and Extend” Treatment Algorithms Versus Ranibizumab As Needed in Patients With Macular Edema and Visual Impairment Secondary to Diabetes Mellitus |
https://ClinicalTrials.gov/show/NCT01171976 |
Completed |
Novartis |
2013-04-30 |
| NCT01103206 |
Evaluation of a Cincalcet Suppression Test |
https://ClinicalTrials.gov/show/NCT01103206 |
Completed |
University Hospital, Rouen |
2013-02-28 |
| NCT00989989 |
Efficacy and Safety of Ranibizumab (Intravitreal Injections) in Patients With Visual Impairment Due to Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00989989 |
Completed |
Novartis |
2011-08-31 |
| NCT00985231 |
Performance Evaluation of Contact Lenses Among a Population of Adapted Contact Lens Wearers |
https://ClinicalTrials.gov/show/NCT00985231 |
Completed |
Bausch & Lomb Incorporated |
2009-11-30 |
| NCT00901186 |
Efficacy and Safety of Ranibizumab (Intravitreal Injections) Versus Laser Treatment in Patients With Visual Impairment Due to Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00901186 |
Completed |
Novartis |
2012-08-31 |
| NCT00827632 |
Obesity, Oral Contraception, and Ovarian Suppression |
https://ClinicalTrials.gov/show/NCT00827632 |
Completed |
Columbia University |
2008-12-31 |
| NCT03571841 |
Sexual Health and Rehabilitation After Ovarian Suppression Treatment |
https://ClinicalTrials.gov/show/NCT03571841 |
Completed |
Dana-Farber Cancer Institute |
2019-12-01 |
| NCT03141164 |
Peripheral Vision Training Study |
https://ClinicalTrials.gov/show/NCT03141164 |
Recruiting |
University of Alabama at Birmingham |
2020-09-30 |
| NCT00687804 |
A 12 Month Core Study to Assess the Efficacy and Safety of Ranibizumab (Intravitreal Injections) in Patients With Visual Impairment Due to Diabetic Macular Edema and a 24 Month Open-label Extension Study |
https://ClinicalTrials.gov/show/NCT00687804 |
Completed |
Novartis |
2010-01-31 |
| NCT00395122 |
Optical Coherence Tomography Measurements in Eyes With Band Atrophy |
https://ClinicalTrials.gov/show/NCT00395122 |
Completed |
University of Sao Paulo |
NA |
| NCT00342108 |
Cortical Visual Impairment and Visual Attentiveness |
https://ClinicalTrials.gov/show/NCT00342108 |
Completed |
Sheba Medical Center |
2009-07-31 |